| 42nd week of 2010 patent applcation highlights part 48 |
| Patent application number | Title | Published |
|---|
| 20100267800 | N-Alkyl-Hydroxamic Acid-Isoindolyl Compounds and Their Pharmaceutical Uses - The invention encompasses novel N-alkyl-hydroxamic acid-isoindolyl compounds, pharmaceutical compositions of these compounds, and methods of using these compounds and compositions for treatment or prevention of various diseases and disorders, for example, diseases associated with PDE4. | 2010-10-21 |
| 20100267801 | CYCLOHEXYL SULPHONES FOR TREATMENT OF CANCER - Sulphones of formula (I) are disclosed for use in treatment of cancer. | 2010-10-21 |
| 20100267802 | DELIVERY METHOD - The present invention relates, in general, to RNA silencing and, in particular, to a method of effecting targeted delivery of an RNA silencing moiety using a targeting moiety that binds to a cell surface receptor and mediates internalization of the RNA silencing moiety to be accessible to Dicer. Also provided is a chimeric nucleic acid molecule comprised of a targeting moiety and an RNA silencing moiety, wherein the targeting moiety is an aptamer and the RNA silencing moiety comprises a Dicer substrate. | 2010-10-21 |
| 20100267803 | Regulators Of Fat Metabolism As Anti-Cancer Targets - Embodiments of the invention provide methods of identifying agents that reduce or prevent the proliferation of breast cancer cells, or kill them, in particular by interfering with the expression of the transcription factors NR1D1 and PPARγ or the expression of genes whose transcription they activate or the activity of the proteins translated from those transcripts. | 2010-10-21 |
| 20100267804 | DIFFERENTIAL EXPRESSION OF MICRORNAS IN NONFAILING VERSUS FAILING HUMAN HEARTS - The present invention discloses specific miRNAs as novel biomarkers and therapeutic targets in the treatment of heart failure. Methods of treating or preventing heart failure in a subject by administering mimics or inhibitors of these particular miRNAs are disclosed. A method of diagnosing or prognosing heart failure in a subject by determining the level of expression of one or more miRNAs is also described. | 2010-10-21 |
| 20100267805 | TARGETING OPPOSITE STRAND REPLICATION INTERMEDIATES OF SINGLE-STRANDED VIRUSES BY RNAI - The invention relates to methods and compositions for modulating viral replication through double-stranded RNA-mediated gene silencing (RNAi), wherein the antiviral methods and compositions preferentially target opposite strand replication intermediates of single-stranded RNA viruses. | 2010-10-21 |
| 20100267806 | LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 AND VEGF GENES - This invention relates to compositions containing double-stranded ribonucleic acid (dsRNA) in a lipid formulation, and methods of using the compositions to inhibit the expression of the Human kinesin family member 11 (Eg5) and Vascular Endothelial Growth Factor (VEGF), and methods of using the compositions to treat pathological processes mediated by Eg5 and VEGF expression, such as cancer. | 2010-10-21 |
| 20100267807 | ALLEVIATING NEUROPATHIC PAIN WITH EETS AND SEH INHIBITORS - The invention discloses methods of using cis-epoxyeicosantrienoic acids (“EETs”), inhibitors of soluble epoxide hydrolase (“sEH”), or a combination of an EET and an inhibitor of sEH, to alleviate neuropathic pain in subjects suffering from such pain. | 2010-10-21 |
| 20100267808 | Bispecific Antisense Oligonucleotides that Inhibit IGFBP-2 and IGFBP-5 and Methods of Using Same - Bispecific antisense oligonucleotides which consist essentially of a sequence of bases that is complementary to portions of both the gene encoding human IGFBP-2 and the gene encoding human IGFBP-5 are useful in as antisense therapeutics in the treatment of endocrine-regulated cancers. | 2010-10-21 |
| 20100267809 | DOUBLE STRANDED NUCLEIC ACID TARGETING LOW COPY PROMOTER-SPECIFIC RNA - The present invention relates to transcriptional gene silencing (TGS) in mammalian, including human, cells that is mediated by small interfering RNA (siRNA) molecules. The present invention also relates to a double stranded nucleic acid that directs methylation of histones associated with target genes that produce low copy promoter-specific RNA. It has been found that siRNAs can be used to direct methylation of histones in mammalian, including human, cells. | 2010-10-21 |
| 20100267810 | METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL DISEASE - This invention relates to methods and compositions for treating neurological disease, and more particularly to methods of delivering iRNA agents to neural cells for the treatment of neurological diseases. | 2010-10-21 |
| 20100267811 | RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS - RNA interference is provided for inhibition of tumor necrosis factor α (TNFα) by silencing TNFα cell surface receptor TNF receptor-1 (TNFR1) mRNA expression, or by silencing TNFα converting enzyme (TACE/ADAM17) mRNA expression. Silencing such TNFα targets, in particular, is useful for treating patients having a TNFα-related condition or at risk of developing a TNFα-related condition, such as ocular angiogenesis, retinal ischemia, and diabetic retinopathy. | 2010-10-21 |
| 20100267812 | GENE THERAPY FOR AMYOTROPHIC LATERAL SCLEROSIS AND OTHER SPINAL CORD DISORDERS - This disclosure provides methods and compositions for treating disorders or injuries that affect motor function and control in a subject. In one aspect, the invention a transgene product is delivered to a subject's spinal cord by administering a recombinant neurotrophic viral vector containing the transgene to the brain. The viral vector delivers the transgene to a region of the brain which is susceptible to infection by the virus and which expresses the encoded recombinant viral gene product. Also provided are compositions for delivery of a transgene product to a subject's spinal cord by administering a recombinant neurotrophic viral vector containing the transgene to the subject's brain. | 2010-10-21 |
| 20100267813 | Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs - Compounds, compositions and methods are provided for modulating the expression and function of small non-coding RNAs. The compositions comprise oligomeric compounds, targeted to small non-coding RNAs. Methods of using these compounds for modulation of small non-coding RNAs as well as downstream targets of these RNAs and for diagnosis and treatment of disease associated with small non-coding RNAs are also provided. | 2010-10-21 |
| 20100267814 | Targeting MicroRNAs for the Treatment of Liver Cancer - Provided herein are methods for the treatment of liver cancer. These methods encompass the administration of a compound comprising a modified oligonucleotide, wherein the modified oligonucleotide is targeted to a miRNA. Also provided herein are compositions for the treatment of liver cancer. Such compositions include compounds comprising a modified oligonucleotide, wherein the modified oligonucleotide is targeted to a miRNA. Certain miRNAs have been identified as overexpressed in liver cancer, such as, for example, hepatocellular carcinoma, and are thus selected for targeting by modified oligonucleotides. Further, certain miRNAs have been identified as overexpressed in hepatocellular carcinoma cells exposed to dioxin, and are thus selected for targeting by modified oligonucleotides. Antisense inhibition of certain of these miRNAs has been found to inhibit cell proliferation and induce apoptosis. | 2010-10-21 |
| 20100267815 | PFKFB4 Inhibitors And Methods Of Using The Same - Methods of reducing expression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (PFKFB4) and methods of treating a cancer in a cell are provided, the methods including contacting a cell with an effective amount of a PFKFB4 inhibitor. Short hairpin RNA (shRNA) and small interfering RNA (siRNA) inhibitors of PFKFB4 and their methods of use are also provided. | 2010-10-21 |
| 20100267816 | HUMAN ANTI-AMYLOID BETA PEPTIDE ANTIBODY AND FRAGMENT OF SAID ANTIBODY - A human anti-amyloid β peptide (hereinafter referred to as “Aβ”) antibody that binds to Aβ to thereby inhibit aggregation of Aβ molecules, and a fragment of said antibody are provided. The antibody and a fragment thereof according to the present invention, comprising a variable region of a human-derived anti-Aβ antibody, strongly reacts with Aβ to thereby inhibit its aggregation and hence may be used as a medicament for the prophylaxis and treatment of Alzheimer dementia. | 2010-10-21 |
| 20100267817 | LYOPHILIZED PHARMACEUTICAL COMPOSITION WITH IMPROVED RECONSTITUTION TIME CONTAINING TAXANE DERIVATIVES AND METHOD OF MANUFACTURING THE SAME - The present invention relates to a lyophilized composition with an improved reconstitution time comprising a taxoid and a method thereof. More specifically, the present invention relates to a lyophilized composition with an improved reconstitution time prepared by mixing and dissolving a taxoid; cyclodextrin (CD); a hydrophilic polymer selected from the group consisting of hydroxypropylmethyl CeIIuIoSe (HPMC), polyethylene glycol (PEG), and polyvinylpyrrolidone (PVP); and a bulking agent of saccharides in water for injection; and lyophilizing the mixture, and a method thereof. | 2010-10-21 |
| 20100267818 | STABILIZED SINGLE-LIQUID PHARMACEUTICAL COMPOSITION CONTAINING DOCETAXEL - This invention relates to a single-liquid pharmaceutical composition for injection containing docetaxel. The composition includes (A) docetaxel and pharmaceutically acceptable salts thereof, (B) a surfactant selected from the group consisting of polysorbate, polyoxyethylene glycol ester and polyoxyethylene castor oil derivatives, (C) a solvent comprising anhydrous ethanol in a concentration range of 100 to 800 mg/ml, in an injectable solution, and (D) a pH adjuster of an amount suitable for adjusting the pH of the liquid composition to 5 or less. The composition may be directly diluted in a perfusion liquid even without the use of an intermediary dilute solution in case the composition is used for injectable preparations since the composition is in a single liquid phase. Furthermore, the composition is suitable for effective administration of docetaxel since the pharmaceutical stability of the composition is significantly improved. | 2010-10-21 |
| 20100267819 | PHARMACEUTICAL COMPOSITION FOR DIABETIC NEPHROPATHY AND ITS PREPARATION AND APPLICATION - The invention relates to a pharmaceutical composition for diabetic nephropathy and its preparation, and the application in preparing of medicine for diabetic nephropathy. The pharmaceutical composition is made up of at least one of 7-hydroxycoumarin and 7-hydroxy-6-methoxycoumarin as active ingredient, and the weight percentage of active ingredient is 0.1-99.5%. Moreover, the pharmaceutical composition is mainly used for the prevention and cure of diabetic nephropathy. For the abundant material, remarkable effect on prevention and cure for diabetic nephropathy and convenience for use, it will be a new facultative drug for patients. | 2010-10-21 |
| 20100267820 | ANTIADHESION AGENTS - Vitamin E succinate derivatives according to formula I: | 2010-10-21 |
| 20100267821 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR IRRITABLE BOWEL SYNDROME - The present invention provides a prophylactic or therapeutic agent for irritable bowel syndrome, which comprises a compound represented by formula (I): | 2010-10-21 |
| 20100267822 | AURONES AS ESTROGEN RECEPTOR MODULATORS AND THEIR USE IN SEX HORMONE DEPENDENT DISEASES - The invention relates to aurones and extracts comprising them useful in the prophylactic and/or therapeutic treatment of an animal (including a human) with an estrogen receptor (ER) related disease or condition of the animal or human body, as well as methods, uses and other inventions related thereto. | 2010-10-21 |
| 20100267823 | AURONES AS SELECTIVE PDE INHIBITORS AND THEIR USE IN NEUROLOGICAL CONDITIONS AND DISORDERS - The invention relates to aurones and extracts comprising them useful in the prophylactic and/or therapeutic treatment of an animal (including a human) with a phosphodiesterase (PDE) dependent disease or condition of the central nervous system, as well as methods, uses and other inventions related thereto. | 2010-10-21 |
| 20100267824 | STABLE OXALIPLATIN COMPOSITION FOR PARENTERAL ADMINISTRATION - The present invention relates to a stable parenteral composition of oxaliplatin having pH range in between 3 to 4.5, which comprises of a solution of oxaliplatin in water wherein the said pH is attained by sparging of carbon dioxide in the composition. Further, a method for the preparation of oxaliplatin composition of the present invention is also disclosed. | 2010-10-21 |
| 20100267825 | TREATMENT OF SKIN DAMAGE - Methods and apparatus are disclosed for diagnosing and treating oxidative skin damage in a subject. The therapeutic method can comprise: (i) diagnosing a level of oxidative skin damage in a sample comprising stratum corneum of the subject; and (ii) recommending a therapeutic regime for treatment of oxidative skin damage in the subject, wherein said recommendation comprises a recommendation to administer a pharmaceutical formulation comprising an amount of one or more specific synthetic SOD/catalase mimetics sufficient to treat the level of oxidative skin damage of the subject as diagnosed. The diagnostic method can further include obtaining a sample from the stratum corneum of a subject; measuring the level of at least one oxidized substance in the sample; and comparing a detected level of the oxidized substance with a standard, whereby an elevated level of the oxidized substance is indicative of skin damage. | 2010-10-21 |
| 20100267826 | Treatment of ischemic episodes and cerebroprotection through Prostaglandin E2 (PGE2) EP2 and/or EP4 receptor agonists - The present invention provides compositions and methods for treating an ischemic episode using PGE | 2010-10-21 |
| 20100267827 | PHENYL-PRENYL-ETHER DERIVATIVES FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS - The present invention is related to a family of phenyl-prenyl-ether derivatives of formula (I), and to their use in the treatment of cognitive, neurodegenerative or neuronal diseases or disorders, such as Alzheimer's disease or 5 Parkinson's Disease. The present invention also relates to pharmaceutical compositions comprising the same. Further, the present invention is directed to the use of the compounds in the manufacture of a medicament for the treatment and/or prevention of a cognitive, neurodegenerative or neuronal disease or disorder. | 2010-10-21 |
| 20100267828 | DHA DERIVATIVES AND THEIR USE AS MEDICAMENTS - The present disclosure relates to compounds of the general formula (I): | 2010-10-21 |
| 20100267829 | Pharmaceutical composition comprising low concentrations of environment pollutants - The invention relates to a process for decreasing the amount of environmental pollutants in a mixture comprising a fat or an oil, being edible or for use in cosmetics, the fat or oil containing the environmental pollutants, which process comprises the steps of adding a volatile working fluid to the mixture, where the volatile working fluid comprises at least one of a fatty acid ester, a fatty acid amide, a free fatty acid and a hydro-carbon, and subjecting the mixture with the added volatile working fluid to at least one stripping processing step, in which an amount of environmental pollutant present in the fat or oil, being edible or for use in cosmetics, is separated from the mixture together with the volatile working fluid. The present invention also relates to a volatile environmental pollutants decreasing working fluid, for use in decreasing an amount of environmental pollutants present in a fat or oil, being edible or for use in cosmetics. In addition, the present invention relates to a health supplement, a pharmaceutical and an animal feed product prepared according to the process mentioned above. | 2010-10-21 |
| 20100267830 | METHODS AND COMPOSITIONS FOR PROMOTING THE NEUROLOGICAL DEVELOPMENT OF AN INFANT - The present invention relates to methods for promoting the neurological development of an infant by administration of fatty acids and compositions comprising same, wherein the fatty acids are enriched with respect to docosahexaenoic acid (DHA) content. | 2010-10-21 |
| 20100267831 | Amino Acid-Containing Composition for Preventing or Remedying Decrease in the Skeletal Muscle of Aged People - The present invention provides an amino acid-containing composition for preventing or remedying a decrease in skeletal muscle mass of aged people, comprising L-leucine at a molar composition ratio of 35% or more with respect to total of essential amino acids. According to the invention, the protein anabolism of skeletal muscle can be promoted to prevent or remedy a decrease of the skeletal muscle mass of aged people. | 2010-10-21 |
| 20100267832 | METHOD FOR TREATING MACULAR DEGENERATION - Disclosed is a method for treating macular degeneration in a mammalian subject, which comprises administering to the subject in need thereof an effective amount of a 15-keto-prostaglandin compound such as 13,14-dihydro-15-keto-20-ethyl-prostaglandin F | 2010-10-21 |
| 20100267833 | Compositions and methods for preventing or treating an inflammatory response - The present invention relates to methods for modulating the inflammatory response of respiratory tract cells using an agent that increases ceramide levels in the cells of the respiratory tract. | 2010-10-21 |
| 20100267834 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR DIFFERENTIALLY ALTERING GENE EXPRESSION TO PROVIDE NEUROPROTECTION FOR THE ANIMAL CENTRAL NERVOUS SYSTEM AGAINST THE EFFECTS OF ISCHEMIA, NEURODEGENERATION, TRAUMA AND METAL POISONING - Pharmaceutical compositions for treating and/or pre-treating or preconditioning the animal central nervous system against the effects of Alzheimer's Disease including the associated neurodegeneration and cognitive, behavioral and physical impairments. In one embodiment, an effective dose of deferoxamine (DFO) is administered to the upper one-third of the subject patient's nasal cavity to effectively bypass the blood-brain barrier, thereby allowing application of the DFO dose directly to the central nervous system. | 2010-10-21 |
| 20100267835 | Methods of treating disorders of trigeminalvascular activation - Alpha-aminoamide derivatives useful in the treatment of disorders of trigeminalvascular activation are disclosed. | 2010-10-21 |
| 20100267836 | NOVEL MELATONIN LIGANDS HAVING ANTIDEPRESSANT ACTIVITY AS WELL AS SLEEP INDUCING PROPERTIES - Novel melatonin ligands of Formula I: | 2010-10-21 |
| 20100267837 | USE OF AT LEAST ONE OXIME DERIVATIVE OF 3,5-SECO-4-NOR-CHOLESTANE AS ANTIOXIDANTS - The invention relates to the use of at least one oxime derivative of 3,5-seco-4-norcholestane as antioxidants in the cosmetics and food fields, and as antioxidant preservatives that can be used, in particular, in cosmetic, food and pharmaceutical products. | 2010-10-21 |
| 20100267838 | PULVERULENT CAROTENOID PREPARATION FOR COLOURING DRINKS - The present invention relates to pulverulent compositions of at least one carotenoid selected from the group consisting of β-carotene, astaxanthin, canthaxanthin, citranaxanthin, lycopene and lutein, a process for the production of these pulverulent compositions, and the use of the pulverulent compositions. | 2010-10-21 |
| 20100267839 | Diarylalkanes as potent inhibitors of binuclear enzymes - The present invention implements a strategy that combines an enzyme inhibition assay with a chemical dereplication process to identify active plant extracts and the particular compounds—diarylalkanes and/or diarylalkanols within those extracts that specifically inhibit binuclear enzyme function. Included in the present invention are compositions of matter comprised of one or more of diarylalkanes and/or diarylalkanols, which inhibit the activity of binuclear enzymes, particularly tyrosinase and which prevent melanin overproduction. The present invention also provides a method for inhibiting the activity of a binuclear enzyme, particularly tyrosinase and a method for preventing and treating diseases and conditions related to binuclear enzyme function. The present invention further includes a method for preventing and treating melanin overproduction and diseases and conditions of the skin related thereto. The method for preventing and treating diseases and conditions related to binuclear enzyme function and melanin overproduction is comprised of administering to a host in need thereof an effective amount of a composition comprising one or more diarylalkanes and/or diarylalkanols synthesized and/or isolated from one or more plants together with a pharmaceutically acceptable carrier. | 2010-10-21 |
| 20100267840 | STABILIZERS FOR HYDROPHOBIC COMPONENTS IN PERSONAL CARE COMPOSITIONS - The present invention provides personal care compositions, as well as methods for stabilizing a degradable of reactive hydrophobic, cosmetically acceptable, component in an aqueous composition. | 2010-10-21 |
| 20100267841 | Composition for Topical Use Containing an Extract of Stryphnodendron; Its Preparation As Well As Its Application - The present invention relates to topical compositions containing extracts of the plant genus | 2010-10-21 |
| 20100267842 | Emulsions of Perfluorocarbons - The subject application provides for an emulsion comprising an amount of a perfluorocarbon liquid dispersed as particles within, a continuous liquid phase, wherein the dispersed particles have a monomodal particle size distribution and uses thereof. The subject application also provides for a method of manufacturing a perfluorocarbon emulsion, a process for preparing a pharmaceutical product containing a PFC emulsion and a process for validating a batch of an emulsion for pharmaceutical use. | 2010-10-21 |
| 20100267843 | MIXED FLUOROALKYL-ALKYL SURFACTANTS - A surfactant of formula 1 | 2010-10-21 |
| 20100267844 | ALKYLENE OXIDE-CAPPED SECONDARY ALCOHOL ALKOXYLATES USEFUL AS SURFACTANTS - Disclosed are compositions of the formula wherein R | 2010-10-21 |
| 20100267845 | (METH)ACRYLIC ACID/ALKYL (METH)ACRYLATE ESTER COPOLYMER AND COSMETIC PREPARATION CONTAINING THE SAME - A (meth)acrylic acid/alkyl (meth)acrylate ester copolymer containing constituents of 95.42 to 97.48% by mass of (meth)acrylic acid, 2.43 to 4.30% by mass of an alkyl (meth)acrylate ester of which alkyl group has 18 to 24 carbon atoms, and 0.08 to 0.30% by mass of a compound having two or more ethylenically unsaturated groups; and cosmetics blended with the copolymer. According to the copolymer of the present invention, a neutral viscous aqueous solution having a high viscosity can be formed even in the presence of an electrolyte in a relatively high concentration, without being affected by its temperature and electrolytic concentration; therefore, the copolymer of the present invention can be suitably used in cosmetics and the like. | 2010-10-21 |
| 20100267846 | MOLECULAR DELIVERY VEHICLE - An isolated caveolin containing vesicle comprising a caveolin protein and at least one lipid, wherein at least about 30% of the at least one lipid is selected from phosphatidylethanolamine and phosphatidylglycerol is disclosed. Also disclosed is a method of making an isolated caveolin containing vesicle, an isolated caveolin containing vesicle comprising a recombinant caveolin protein, an isolated caveolin containing delivery vesicle, a method of making an isolated caveolin containing delivery vesicle and a method of treatment of a disease or condition by delivery of a molecule using the isolated caveolin containing delivery vesicle. | 2010-10-21 |
| 20100267847 | METHOD OF IMPROVING SWEETNESS QUALITIES OF STEVIA EXTRACT - The present invention provides a technique for improving the sweetness of | 2010-10-21 |
| 20100267848 | METHOD AND REACTOR FOR THE PREPARATION OF METHANOL - Method and reactor for performing Fischer-Tropsch (FT) synthesis with controlled steam partial pressure by introducing cool points in the FT reactor, typically in form of cooled solid surfaces. At the surface, the low temperature will force condensation of the water into a liquid film. Thereby, the partial pressure of steam in the gas and reactor will not exceed significantly the vapour partial pressure at the liquid film and water from the gas stream will be removed as it is produced, i.e. steam induced deactivation is avoided. In addition, the decrease of hydrogen and carbon monoxide partial pressures due to dilution by steam will be kept low ensuring a constant high reaction rate. | 2010-10-21 |
| 20100267849 | GELATOR FOR PRODUCING A GEL ELECTROLYTE - A gelator for producing a gel electrolyte is a copolymer and comprises multiple major monomeric units, multiple minor monomeric units and multiple optional components. The major monomeric units comprise acrylonitrile (AN) monomeric units that have good ionic conductivity and coordinating sites for lithium ions to be dissolved with a liquid-electrolytic solvent. The minor monomeric units are a combination of at least one type monomeric unit, and the combination of at least one type monomeric unit is selected from a group consisting of vinyl acetate (VA), allyl acetate (AA), styrene, acrylamide and at least one reactive compound. A gel electrolyte is a mixture of a gelator and a liquid-electrolytic solvent. | 2010-10-21 |
| 20100267850 | PROCESS FOR PRODUCING EXPANDED POLYOLEFIN RESIN PARTICLES AND EXPANDED POLYOLEFIN RESIN PARTICLES - Provided is a process for producing expanded polyolefin resin particles whose cells are not made nonuniform or extremely smaller as seen in conventional expanded particles, whose cell diameter and expansion ratio can be easily controlled independently, and which, when subjected to in-mold expansion molding, give in-mold expanded molded products satisfactory in fusibility and excellent in surface properties. The process is a process for producing expanded polyolefin resin particles by: dispersing polyolefin resin particles together with an aqueous dispersion medium into a closed vessel; heating the polyolefin resin particles up to or above a softening temperature of the polyolefin resin particles; and releasing the polyolefin resin particles into a zone whose pressure is lower than an internal pressure of the closed vessel, with use as a foaming agent of water serving as the dispersion medium, the polyolefin resin particles being composed of a polyolefin resin composition including: polyolefin resin; a substance selected from among polyethylene glycol, polyvalent alcohol having a carbon number of not less than 3 to not more than 6, and a water-absorbing substance having no function of forming foaming nuclei; and a foam nucleating agent. | 2010-10-21 |
| 20100267851 | FIRE RESISTANT MATERIALS - A method for forming a fire resistant material is disclosed. The method comprises providing a plurality of expandable beads of a polymeric material. The beads are coated with an exfoliable graphite. The exfoliable graphite is adhe red to the beads with a resin having a solubility parameter of the polymeric material. The beads are thereafter caused or allowed expand and fuse. | 2010-10-21 |
| 20100267852 | POLYMERIC FOAM COALESCING AGENT - A coalescing agent for facilitating the separation of a non-aqueous phase from an aqueous phase of an aqueous medium, said agent consisting of particles of a polymeric foam material having: an IFD no. of 40 or higher (i.e. at least 40); a BR no. of 35 or higher (at least 35); a SF no. of 1.8 or higher (i.e. at least 1.8) and a density of 42 kg/m | 2010-10-21 |
| 20100267853 | POLYMER-BASED FIRE-RETARDING FORMULATIONS - The invention provides a formulation for rendering surfaces fireproof by application thereon. | 2010-10-21 |
| 20100267854 | POLYURETHANE FOAM CONTAINING SILICONE - Silicone-containing polyurethane foams of low density may be prepared from hyperbranched siloxanes. | 2010-10-21 |
| 20100267855 | Method and Apparatus for Continuous Production of Partially Polymerized Compositions and Polymers Therefrom - Methods and apparatus for continuous production of a partially polymerized composition according to the invention comprise those that facilitate continuously providing polymerizable composition comprising one or more monomers to an angled plane at an elevated position thereon; irradiating the polymerizable composition to form the partially polymerized composition; and continuously removing the partially polymerized composition from the angled plane at a lower position thereon, wherein the angle of the angled plane facilitates free flow of polymerizing composition from the elevated position to the lower position. | 2010-10-21 |
| 20100267856 | CEMENT FOR DENTAL APPLICATIONS - A cement for dental use, containing a first agent and a second agent, wherein both of the first agent and the second agent contain a polymerizable monomer (a) and a filler (b), wherein the first agent and/or the second agent further contains a photopolymerization initiator (c), wherein further as a chemical polymerization initiator (d), either one of the first agent and the second agent contains an oxidizing agent (f) and the other contains a reducing agent (g), the oxidizing agent (f) and the reducing agent (g) constituting a redox polymerization initiator, wherein the photopolymerization initiator (c) contains an α-diketone, and the photopolymerization initiator (c) is contained in a total amount of from 0.010 to 0.100 parts by weight, based on 100 parts by weight of the total amount of the polymerizable monomer (a), wherein the chemical polymerization initiator (d) is contained in a total amount of from 0.001 to 20 parts by weight, based on 100 parts by weight of the total amount of the polymerizable monomer (a), and wherein a cured product has a compression modulus immediately after photocuring of from 100 to 400 MPa, and a compression modulus after 24 hours from photocuring of 500 MPa or more. The cement for dental use of the present invention is suitably used for adhering the dentine and a crowning restorative material in the field of dental therapy, or the like. | 2010-10-21 |
| 20100267857 | SALT COMPOUND, CATIONIC POLYMERIZATION INITIATOR AND CATIONICALLY POLYMERIZABLE COMPOSITION - Provided are a salt compound, cationic polymerization initiator and cationically polymerizable composition, which have a superior acid-generating capacity and high sensitivity, and are free from coloration. The salt compound is represented by the following general Formula (1): | 2010-10-21 |
| 20100267858 | DICHROIC GUEST-HOST POLARIZER COMPRISING AN ORIENTED POLYMER FILM - A dichroic guest-host polarizer comprises an oriented polymerized liquid crystal host and aligned therewith a dichroic guest. The dichroic ratio of the polarizer is about 15 or more. The polarizer may have a small thickness, be manufactured using a wet deposition method, optionally in accordance with a desired pattern, and be provided on the inside of a liquid crystal cell. Polymerizable liquid crystals having a highly ordered mesophase which may be suitable used to obtain highly oriented polymer films such as polarizer films are disclosed. | 2010-10-21 |
| 20100267859 | ADDITIVE FOR COATINGS CONTAINING METALLIC NANOPARTICLES AND PREPARATION METHOD THEREFOR - The present invention relates to a method of obtaining an additive for coatings that contains nanoparticles of one or more compounds, preferably metallic, selected in relation to the property that is desired to be transferred to the coating, which comprises a first pretreatment phase in which the water content of the active agent is reduced, replacing it with a vehicle compatible with the coating, and a second phase in which it is mixed with a resin compatible with the coating, a dispersant and a solvent, which are also compatible with it. The additive produced by this method contains nanoparticles of one or more compounds, preferably metallic, which become dispersed homogeneously in the coating once incorporated therein. | 2010-10-21 |
| 20100267860 | THERMOPLASTIC COMPOSITION CONTAINING A MOLD RELEASE AGENT WHICH IS BASED ON AN ESTER OF DI- OR POLYGLYCEROLS AND AT LEAST ONE CARBOXYLIC ACID - The present invention relates to a thermoplastic composition containing a thermoplastic polymer, a mold release agent, and optionally further additives, wherein the mold release agent contains an ester of at least one alcohol component based on two or more glycerol units, and at least one carboxylic acid or a derivative of a carboxylic acid or both. The present invention also relates to a method for producing a thermoplastic composition, to the thermoplastic composition obtainable by this method, to a method for producing a molded article based on a thermoplastic composition, to a molded article obtainable by this method and also to the use of a mold release agent. | 2010-10-21 |
| 20100267861 | Polymer mixture - The invention relates to a polymer mixture, especially for decorative surfaces in an automobile interior, that displays an improvement in long-term functionality with respect to the properties of writing sensitivity, soiling and cleaning behavior, abrasion resistance, and antisqueak behavior, both in the delivery condition and in the used condition. The inventive polymer mixture comprises: 0%-50% by weight of at least one aqueous polyurethane dispersion and/or polyester dispersion and/or polyether dispersion and/or polyester-polyacrylate dispersion and/or polyacrylate-polyurethane dispersion and/or polyacrylate dispersion and/or of a dispersion based on at least one of these and/or several other polymers; 1%-60% by weight of at least one aqueous polyurethane dispersion and/or polyesterpolyol dispersion and/or polyetherpolyol dispersion and/or polyacrylatepolyol dispersion and/or of a dispersion based on at least one of these and/or two or more other polymers, the polymer or at least one polymer being functionalized with OH groups and/or NH groups and possessing an OH content or NH content of between 0.3% and 6.0% by weight, based on the nonvolatile fraction of the total amount of the polymers; 0%-40% by weight of at least one nonfunctionalized slip additive; 1%-40% by weight of at least one functionalized slip additive; 0.2%-50% by weight of at least one crosslinker or crosslinker system; 0%-75% by weight of at least one matting agent; 0%-50% by weight of diluent; 0%-50% by weight of other adjuvants, based on the nonvolatile fraction of the total amount of polymers. | 2010-10-21 |
| 20100267862 | METHODS OF PREVENTING FROST FORMATION AND FACILITATING THE REMOVAL OF WINTER PRECIPITATION RELATIVE TO A WINDSHIELD AND COMPOSITIONS FOR USE THEREIN - Disclosed herein is a winter precipitation barrier composition, comprising: a retaining agent, a solvent, and optionally, an auxiliary component, such as a rheology/viscosity modifier, surfactant, detergent, foaming/defoaming additive, humectant, dye, colorant, fragrance, or a combinations thereof. In one embodiment, the retaining agent comprises a primarily hydrophobic monomer or a hydrophilic monomer. | 2010-10-21 |
| 20100267863 | REINFORCING CORD AND RUBBER PRODUCT USING THE SAME - A reinforcing cord of the present invention is a reinforcing cord ( | 2010-10-21 |
| 20100267864 | MAN-MADE MINERAL FIBRE FOR THREE-DIMENSIONAL REINFORCEMENT OF A CEMENT PRODUCT - The present invention provides a bicomponent fiber for three-dimensional reinforcement of a cement product characterized in that it represents a coaxial core-coat fiber wherein the core comprises a thermoplastic polymer and the coat either comprises thermoplastic polymer resistant to environment having pH>11 and one or more hydrophilic and/or surface active substance(s) in an amount of 3 to 30%% of the total weight of the coat, or the coat comprises thermoplastic polymer resistant to environment having pH>11 grafted with active or unsaturated monomers of one or different kinds constituting 3 to 25% of total weight of the coat, wherein the surface tension of the coat is at least 45 mN/m. The invention also provides a method for production of said fiber, a cement product comprising such fiber and a method of production of said cement product. | 2010-10-21 |
| 20100267865 | COMPOSITIONS OF CONTROLLED-BREAKAGE CATIONIC ASPHALT MICROSURFACING EMULSIONS - Compositions of controlled-breakage cationic asphalt microsurfacing emulsions especially formulated to provide extra-rapid setting on being deposited on paving in coating operations which may be realised during the day, or during the night, under particularly severe ambient conditions for this type of operation, that is to say at temperatures below 15° C. with relative air humidity exceeding 50%, but limited to 65%. Said compositions provide extra-rapid setting because they yield wet cohesion results exceeding 25 kgf-cm in one hour when tested by method ISSA TB-139 under the said ambient conditions of temperature and humidity. | 2010-10-21 |
| 20100267866 | WOOD COMPOSITE MATERIAL AND METHOD FOR MAKING SAME - The invention relates to a wood composite material and to a method for making it. In accordance with the invention, the wood composite material is formed of adhesive laminate waste comprising adhesive material, glue and release material and having been arranged into chaff, the chaff being arranged into the wood composite material. | 2010-10-21 |
| 20100267867 | BLENDS OF BIODEGRADABLE POLYMERS AND ACRYLIC COPOLYMERS - The invention relates to a blend of one or more biodegradable polymers with one or more acrylic copolymers, for the purpose of improving the properties of the biodegradable polymer(s). The biodegradable polymer contains at least 10 weight percent of a biopolymer that is in less than ideal condition for processing. The “compromised” biopolymer may be undried biopolymer, may have a heat history (be “reprocessed”, “regrind” or “recycled”), or both. The acrylic copolymer(s) are present in the blend at a level of 0.1 to 15 weight percent, based on the weight of the total blend. | 2010-10-21 |
| 20100267868 | METHOD OF RECYCLING FIBER-REINFORCED PLASTIC - The present invention provides a method of recycling a fiber-reinforced plastic by which a recycled material of a fiber-reinforced plastic having excellent strength properties can be obtained. The method is a method of recycling a fiber-reinforced plastic comprising carbon fibers and a thermosetting resin (epoxy resin), comprising a first step of producing a harmless material by subjecting a fiber-reinforced plastic B to heat treatment so as to burn off an epoxy resin and a second step of applying a sizing agent to or spraying a sizing agent over the harmless material, producing a strip-shaped harmless material B′, and producing a recycled material containing short carbon fibers during kneading of the strip-shaped harmless material B′ and a thermoplastic resin (polypropylene). | 2010-10-21 |
| 20100267869 | UV STABILIZATION OF A CROSS-LINKABLE POLYOLEFIN COMPOSITION COMPRISING AN ACIDIC SILANOL CONDENSATION CATALYST - The present invention relates to a polyolefin composition comprising (A) a cross-linkable polyolefin with hydrolysable silane groups; (B) and a silanol condensation catalyst characterized in that the ΔF is more than 40 Nm and the cross-linking speed is more than 0.1 Nm/s in the ice test and retention of more than 60% of the elongation at break after 500 h in SEPAP UV exposure, further a polyolefin composition comprising (A) a cross-linkable polyolefin with hydrolysable silane groups; (B) an acidic silanol condensation catalyst, and (C) at least one UV stabilizer that is acidic, i.e. pH equal or less than 6.2, measured at 20-25° C. and with 1 wt % suspension; to an article comprising such a composition, and to the use of such a composition for the production of an article. | 2010-10-21 |
| 20100267870 | ADDITIVE COMPOSITION AND THERMOPLASTIC COMPOSITIONS COMPRISING THE SAME - A thermoplastic additive composition comprises an acetal compound and at least one co-additive. The acetal compound can be the product of the reaction between an alditol or a C1 substituted alditol and a benzaldehyde. The co-additive can be a fatty acid amide compound, a fatty acid ester compound, and/or a fluoropolymer. A thermoplastic composition comprises a thermoplastic (e.g., one or more polyolefins) and an additive composition as described above. | 2010-10-21 |
| 20100267871 | ORGANOPHOSPHONATE OLIGOMERS - This invention provides chlorohydrocarbyloxy phosphonate oligomers, organophosphonate oligomers, and processes for the preparation of such oligomers. The chlorohydrocarbyloxy phosphonate oligomers can be represented by the formula (IV) where R | 2010-10-21 |
| 20100267872 | Stabilized polymer compositions - This invention relates to the thermal stabilization of halogen-containing polymer compositions, more particularly, this invention relates to a poly(vinyl chloride) (PVC) or a chlorinated polyvinyl chloride (cPVC) composition comprising an alkyl tin stabilizer and at least one salt of a polymeric polyacid such as a polycarboxylic acid salt supported on a polymeric material. | 2010-10-21 |
| 20100267873 | Stabilized polymer compositions - This invention relates to the thermal stabilization of halogen-containing polymer compositions, more particularly, this invention relates to a poly(vinyl chloride) (PVC) or a chlorinated polyvinyl chloride (cPVC) composition comprising a methyl tin stabilizer and at least one salt of a polyacid material such as a polycarboxylic acid, a phosphoric acid, or a boric acid. | 2010-10-21 |
| 20100267874 | MIXTURE CONTAINING QUATERNARY AMMONIUM COMPOUND AND ITS USE - The present invention pertains to the use of quaternary organic ammonium compounds for the reduction of efflorescence in building materials. In addition, a mixture containing at least one quaternary organic ammonium compound and at least one water-soluble organic polymer and, optionally, further additives is described. The mixture according to the invention can be prepared by a) at least one quaternary organic ammonium compound and at least one water-soluble organic polymer being mixed with one another in water and the obtained aqueous mixture optionally being subsequently dried, or b) at least one powdery quaternary organic ammonium compound and at least one powdery water-soluble organic polymer being mixed with one another, or c) at least one liquid and/or dissolved quaternary organic ammonium compound being applied on at least one powdery water-soluble organic polymer, in particular by means of spraying, adsorption, mixing, fluidized bed drying and/or granulation. | 2010-10-21 |
| 20100267875 | FLAME RETARDANT ELASTOMER LATICES - A non-halogenated elastomeric latex is disclosed, using as flame retardants, an aqueous dispersion of organoclay and a conventional non-halogenated flame retardant, of which less is needed than conventionally, because of the use of the organoclay. The latex can become a film, sheet, or other article. | 2010-10-21 |
| 20100267876 | WATER BORNE COATING COMPOSITION CONTAINING A POLYESTERAMIDE - Disclosed is a composition containing (i) 1-50 wt. % of a water-soluble, branched polyesteramide, (ii) 1-50 wt. % of a solvent selected from the group of alcohols, ethers, and ether alcohols having a boiling point in the range of 130° to 250° C., and (iii) 0-98 wt. % of water, and its use as an additive to water borne base coat compositions to reduce or eliminate problems of underspray/overspray. | 2010-10-21 |
| 20100267877 | HIGH MELT FLOW POLYMER OF IMPROVED DURABILITY FOR PIPE APPLICATIONS - The present invention relates to a polymer composition, comprising
| 2010-10-21 |
| 20100267878 | Additive for Polymers and Process for Preparation Thereof - The invention concerns a process for preparing an additive for polymers, the additive itself and the use of the additive for improving the surface properties of polymers. | 2010-10-21 |
| 20100267879 | POLYCARBONATE RESIN COMPOSITION, POLYCARBONATE RESIN MOLDED ARTICLE, AND METHOD FOR PRODUCING THE SAME - The present invention aims to provide a polycarbonate resin composition containing, with respect to 100 parts by mass of a composition formed of (A) 60 to 90 parts by mass of an aromatic polycarbonate resin containing a polycarbonate-polyorganosiloxane copolymer and (B) 40 to 10 parts by mass of a glass filler having a refractive index smaller or larger than that of the aromatic polycarbonate resin by 0.002 or less, (C) 0.05 to 2.0 parts by mass of a silicone compound having a reactive functional group and (D) 0.05 to 7.0 parts by mass of glossy particles, a polycarbonate resin molded article obtained by molding the composition, and a method of producing the polycarbonate resin molded article including subjecting the composition to injection molding at a mold temperature of 120° C. or higher to provide the molded article. Provided are a polycarbonate resin composition containing a glass filler, excellent in metallic appearance (having a total light transmittance of 40% or more and a 60° specular gloss of 80 or more), strength, and heat resistance, and provided with high flame retardancy without the use of any flame retardant, a polycarbonate resin molded article obtained by molding the resin composition, and a method of producing the polycarbonate resin molded article. | 2010-10-21 |
| 20100267880 | POLYCARBONATE RESIN COMPOSITION, MOLDED POLYCARBONATE RESIN ARTICLE, AND METHOD FOR PRODUCTION OF THE MOLDED POLYCARBONATE RESIN ARTICLE - Provided is a polycarbonate resin composition which contains specific amounts of a glass filler and glossy particles, which can be molded into an article in which no difference in lightness is visually observed between the left side and the right side of the weld line, and which has excellent optical properties and flame retardancy. The polycarbonate resin composition contains: a composition formed of an aromatic polycarbonate resin (A) and a glass filler (B) having a difference in refractive index 0.002 or less from the aromatic polycarbonate resin of; glossy particles (C-1) having an average particle diameter of 10 μm or more and less than 50 μm; glossy particles (C-2) having an average particle diameter of 50 to 300 μm; a silicone compound (D) having a reactive functional group; and an organic alkali metal salt compound and/or an organic alkali earth metal salt compound (E). Also provided are a polycarbonate resin molded article produced by molding the resin composition, and a method of producing a polycarbonate resin molded article, which is characterized by involving subjecting the resin composition to an injection molding at a mold temperature of 120° C. or higher. | 2010-10-21 |
| 20100267881 | ACICULAR BOEHMITE NANOPARTICLES - Acicular boehmite nanoparticles, methods of making acicular boehmite nanoparticles, and composite materials that contain acicular boehmite nanoparticles are described. The acicular boehmite nanoparticles are prepared in a continuous hydrothermal reactor from a feedstock solution containing a soluble aluminum-containing precursor. | 2010-10-21 |
| 20100267882 | Polyolefin Compositions - A composition is disclosed having: a first component of one or more of: (a) an ethylene octene rubber; (b) an ethylene butene rubber; and/or (c) a hydrogenated styrenic thermoplastic elastomer; and a second component of: (d) a surface modified nanoclay. Related articles, compositions and methods are also described. | 2010-10-21 |
| 20100267883 | Nanotube Polymer Composite Composition and Methods of Making - Embodiments of the invention include compositions comprising a polymer an amount of nanotubes extrusion compounded together. The amount of the nanotubes dispersed in the polymer forms a composition with a storage modulus G′ that does not increase further extrusion compounding of the composition. Extrusion compounded compositions of conductive nanotubes and polymer can be molded into electrically dissipative articles whose resistivity decreases with decreasing shear flow in the molding process. | 2010-10-21 |
| 20100267884 | ARBORESCENT POLYMERS AND PROCESS FOR MAKING SAME - The present invention relates to arborescent polymers and to a process for making same. In one embodiment, the present invention relates to arborescent polymers formed from at least one inimer and at least one isoolefin that have been end-functionalized with a polymer or copolymer having a low glass transition temperature (T | 2010-10-21 |
| 20100267885 | Metal Particle Dispersion Structure, Microparticles Comprising This Structure, Articles Coated With This Structure, And Methods Of Producing The Preceding - A metal particle dispersion structure characteristically comprising (B) 0.005 to 100 weight parts of metal nanoparticles dispersed in (A) 100 weight parts of polymerized polymer, wherein the metal nanoparticles are metal particles obtained by mixing (b1) organohydrogenpolysiloxane and (b2) at least one metal compound which is soluble in component (b3) to uniformity in (b3) cyclic or chain dimethylpolysiloxane or at least one organic solvent. | 2010-10-21 |
| 20100267886 | USE OF HIGHLY BRANCHED POLYMERS IN POLYMER DISPERSIONS FOR GLOSS COLOURS - The present invention relates to a method of producing coatings with increased gloss, to aqueous coating materials for such a method, and to the use of highly branched polymers as an additive for aqueous polymer dispersions for coating materials that lead to coatings having increased gloss. | 2010-10-21 |
| 20100267887 | EPOXY-PHENOLIC RESINS CO-DISPERSIONS - An organic solvent free process to make an aqueous co-dispersion of epoxy resins and at least phenolic novolac resins is reported. The compositions of such co-dispersions are based on blends of epoxy resins and at least a phenolic novolac resin within the profile viscosity versus temperature in the ranges from 1 500 000 to 300 mPas at 80° C. and 10 000 to 20 mPas at 120° C. | 2010-10-21 |
| 20100267888 | POLYVINYL ALCOHOL FIBER-CONTAINING POLYOLEFIN RESIN COMPOSITION AND MOLDED ARTICLE THEREOF - A polyvinyl alcohol fiber-containing polyolefin resin composition, comprising: 1 to 70% by weight of polyvinyl alcohol fibers (A) containing 100 parts by weight of polyvinyl alcohol filaments (A-I) and 0.1 to 10 parts by weight of a sizing agent (A-II); and 30 to 99% by weight of a polyolefin resin composition (I), wherein the polyolefin resin composition (I) contains 0.5 to 40% by weight of a modified polyolefin resin (B) produced by modifying a polyolefin resin with an unsaturated carboxylic acid and/or an unsaturated carboxylic acid derivative and 60 to 99.5% by weight of a polyolefin resin (C) with respect to the total weight of the polyolefin resin composition (I). | 2010-10-21 |
| 20100267889 | IMPACT-MODIFIED POLYCARBONATE COMPOSITIONS FOR THE PRODUCTION OF METALLISED MOULDINGS WITH HOMOGENEOUS SURFACE GLOSS - The invention relates to impact-modified polycarbonate compositions which are distinguished by high heat resistance and good melt flow behaviour. In addition, the mouldings produced from the compositions according to the invention in an injection-moulding process can be metallised, the resulting metallised mouldings having a surface with a particularly high and, in particular, homogeneous gloss. The invention thus also provides the metallised mouldings produced from the compositions according to the invention. | 2010-10-21 |
| 20100267890 | METHOD FOR DISPERSING ALKYD RESINS WITH ASSOCIATIVE POLYMERS IN WATER, FORMULATIONS THUS OBTAINED AND AQUEOUS PAINTS CONTAINING SAME - The invention consists of a method for dispersion in water of an alkyd resin, by means of a polymer having associative hydrophobic groups. The formulations obtained then enable a water-based alkyd paint to be manufactured, without having recourse to surfactants or solvents. | 2010-10-21 |
| 20100267891 | POLYBUTYLENE TEREPHTHALATE RESIN COMPOSITION - The present invention provides a polybutylene terephthalate resin composition which satisfies both performances such as high durability in an environment of heating and cooling cycle, and adhesion property to silicone rubber. Specifically, provided is a polybutylene terephthalate resin composition, exhibiting an excellent adhesion property to silicone rubber, containing: (A) 100 parts by weight of polybutylene terephthalate resin; (B) 5 to 30 parts by weight of a core-shell type polymer having a mean particle diameter of | 2010-10-21 |
| 20100267892 | ISOCYANATE TERMINATED POLYTRIMETHYLENE ETHER POLYOL AND PROCESS FOR MAKING SAME - Polyethers of 1,3-propane diol are terminated with polyisocyanates. The isocyanate terminated polytrimethylene ether polyols provide crosslinking agents that provide coating compositions having short dry time, excellent appearance, and resistance to chipping damage. | 2010-10-21 |
| 20100267893 | LIQUID STABILIZER MIXTURE - A mixture comprising
| 2010-10-21 |
| 20100267894 | POLYMER MODIFIED PIGMENT AND PRODUCTION PROCESS OF THE SAME - A polymer modified pigment having a polymer (P-1) on the surface of a pigment (A), wherein the polymer (P-1) is obtained by copolymerizing a copolymer (B-1) of a polymerizable unsaturated monomer containing at least one polymerizable unsaturated group soluble in a non-aqueous solvent, and at least one kind of polymerizable unsaturated monomer (C), which is soluble in the non-aqueous solvent and either insoluble or poorly soluble following polymerization: and a polymer modified pigment having a polymer (P-2) on the surface of a pigment (A), wherein the polymer (P-2) is obtained by polymerizing at least one kind of polymerizable unsaturated monomer (C) soluble in the non-aqueous solvent and either insoluble or poorly soluble following polymerization, in the presence of an alkyd resin (B-2) soluble in a non-aqueous solvent. | 2010-10-21 |
| 20100267895 | Hydrolytically Degradable Polymers and Hydrogels Made Therefrom - Conjugates between a protein and a water soluble polymer comprising multiple degradable carbonate linkages are provided. | 2010-10-21 |
| 20100267896 | Decreasing allergenicity of natural latex rubber prior to vulcanization - A method for reducing allergenicity of natural latex rubber. The natural latex rubber, prior to its vulcanization, is admixed with aluminum hydroxide to denature the antigenic protein thus reducing the total protein level considerably. Lignin or fumed silica can also be mixed with the aluminum hydroxide to reduce the protein value in latex. Ideally, the aluminum hydroxide is characterized as having a density of approximately 2.42 g/cm3 and molecular weight of 78.00. | 2010-10-21 |
| 20100267897 | THERMOPLASTIC AMPHIPHILIC CO-NETWORKS - The present invention relates generally to thermoplastic amphiphilic networks and/or co-networks. In one embodiment, the present invention relates to thermoplastic (TP) amphiphilic co-networks (APCNs) and the preparation of membranes from such APCNs. In another embodiment, the present invention relates to an amphiphilic network comprising at least one hydrophilic polymer-derived portion, at least one hydrophobic polymer-derived portion and at least one thermoplastic polymer-derived portion. In still another embodiment, the present invention relates to thermoplastic amphiphilic co-networks prepared by combining the chemistries of APCNs and polyurethanes (PUs) and to the preparation of membranes therefrom. | 2010-10-21 |
| 20100267898 | CURABLE COMPOSITION AND METHOD FOR PRODUCING THE SAME - Disclosed herein is a curable composition excellent in workability, adhesion properties, rubber-like properties, storage stability, and quick curability. The curable composition comprises (A) a crosslinkable silyl group-containing organic polymer and (B) a (meth)acrylic polymer obtained by polymerizing a (meth)acrylic monomer having a polymerizable unsaturated bond in the presence of a metallocene compound and a crosslinkable silyl group-containing thiol compound, at least one end of the (meth)acrylic polymer being bonded to a residue, —S—R | 2010-10-21 |
| 20100267899 | THERMOPLASTIC ELASTOMER COMPOSITION AND PRODUCTION PROCESS - A thermoplastic elastomer composition which has excellent cleanability and is suitable for use as a medical rubber supply. It is characterized by comprising a rubber ingredient dynamically crosslinked with a crosslinking agent and a matrix which comprises a thermoplastic resin and in which the crosslinked rubber ingredient has been dispersed, the crosslinking agent comprising a triazine derivative. | 2010-10-21 |
